Ozempic and Wegovy Users Face Hidden Dehydration Risk During Heat Waves

GLP-1 medications such as Ozempic, Wegovy, and Mounjaro have become among the most widely prescribed drugs in the country. This summer, physicians are raising an alert that many patients may not have heard from their prescribers: in extreme heat, the same drugs that suppress appetite and regulate blood sugar can suppress thirst, accelerate fluid loss, and leave users significantly more vulnerable to dehydration and heat illness.

Three Reasons GLP-1 Users Are at Greater Risk

1. The first and most direct problem is thirst suppression. GLP-1 agonists work by mimicking a gut hormone that slows digestion and reduces hunger signals. The same mechanism appears to suppress thirst, meaning users may feel no urge to drink water even as their bodies become progressively dehydrated. During a heat wave, when fluid loss through sweating is continuous, a blunted thirst signal is a particularly dangerous gap.

2. The second issue is gastrointestinal side effects. Nausea, vomiting, and diarrhea are among the most common complaints from users of semaglutide and tirzepatide. Each accelerates fluid loss. When those side effects are active during hot weather, users can lose far more fluid than they are taking in, and may not notice the shortfall until dehydration is already advanced.

3. A third factor involves hormonal effects that are still under study. Some research suggests that GLP-1 drugs may reduce production of vasopressin, the hormone that signals the kidneys to conserve water. If this effect is widespread, GLP-1 users could be retaining less fluid than non-users under identical heat conditions. That research is ongoing and not yet fully established, but physicians are taking it seriously as a reason for added caution. The FDA has separately flagged that severe dehydration in GLP-1 users can raise the risk of acute kidney injury, a consequence beyond heat illness itself.

GLP-1 medications can also lower blood pressure in some patients. Extreme heat independently lowers blood pressure by causing blood vessels to dilate. The combination can increase the risk of dizziness, fainting, and cardiovascular strain in susceptible individuals.